ArticleScientific reports2019

Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer.

Virginia Schmid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.